Nora V. Butta

La Paz, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

The Tissue Factor-TFPI Pathway as a Therapeutic Target in Bleeding Disorders of Unknown Cause.

The Tissue Factor-TFPI Pathway as a Therapeutic Target in Bleeding Disorders of Unknown Cause.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 20, 2026

Immune Thrombocytopenia in Older Adults: Age-Related and Disease-Specific Alterations in Platelets.

Immune Thrombocytopenia in Older Adults: Age-Related and Disease-Specific Alterations in Platelets.

Journal: Aging and disease

Published: May 27, 2026

Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors.

Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors.

Journal: Biomedicines

Published: February 12, 2026

Platelet biology and etiopathogenesis of congenital platelet disorders.

Platelet biology and etiopathogenesis of congenital platelet disorders.

Journal: Blood reviews

Published: February 02, 2026

Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia.

Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia.

Journal: Journal of clinical medicine

Published: January 24, 2026

Age-related and disease-specific changes in B-cell profiles in older adults with immune thrombocytopenia.

Age-related and disease-specific changes in B-cell profiles in older adults with immune thrombocytopenia.

Journal: Frontiers in immunology

Published: January 19, 2026

MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics.

MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics.

Journal: Frontiers in immunology

Published: January 16, 2026

Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring.

Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring.

Journal: Nutrients

Published: November 28, 2025

Real-World Experience with Eptacog Beta for On-Label and Off-Label Indications: The Spanish Experience.

Real-World Experience with Eptacog Beta for On-Label and Off-Label Indications: The Spanish Experience.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 30, 2025

Investigation of the Suitability of the ROTEM Assay to Measure Coagulation Potential in Blood From Patients on Concizumab Prophylaxis.

Investigation of the Suitability of the ROTEM Assay to Measure Coagulation Potential in Blood From Patients on Concizumab Prophylaxis.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 20, 2025

Effect of Tofacitinib on Hemostasis in Patients with Ulcerative Colitis: A Comparative Ex Vivo Study.

Effect of Tofacitinib on Hemostasis in Patients with Ulcerative Colitis: A Comparative Ex Vivo Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 18, 2025

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk.

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk.

Journal: British journal of haematology

Published: March 08, 2025

Showing 1-12 of 54

Last Updated: 09/26/2026